Quince Therapeutics
(NASDAQ) CRTX
Quince Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$26.87M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
CRTX News
CRTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Quince Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
36
CEO
Dirk Thye, MD
Website
quincetx.comHeadquarters
South San Francisco, CA 94080, US
CRTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-4%
Return on Capital
-55%
Return on Assets
-52%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$57.28M
EBITDA
$57.28M
Operating Cash Flow
$31.90M
Capital Expenditure
$257.00K
Free Cash Flow
$32.16M
Cash & ST Invst.
$40.78M
Total Debt
$14.71M
Quince Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
55
N/A
Net Income
$13.44M
+18.8%
EBITDA
$13.45M
+16.9%
Quarterly Fundamentals
Net Cash
$8.41M
-91.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$359.00K
+169.9%
Short Term Debt
$17.52M
N/A
Return on Assets
-51.85%
N/A
Return on Invested Capital
-55.13%
N/A
Free Cash Flow
$16.35M
-1.6%
Operating Cash Flow
$16.42M
-2.0%